首页> 中文期刊>中国现代医生 >难治性幻听患者应用rTMS治疗后幻听评分及血清BDNF水平的变化及意义

难治性幻听患者应用rTMS治疗后幻听评分及血清BDNF水平的变化及意义

     

摘要

Objective To investigate the changes and significance of auditory hallucinations score and serum BDNF levels of refractory auditory hallucinations patients after rTMS therapy. Methods Fifty cases of patients with refractory auditory hallucinations who were treated in our hospital from 2011 to 2013 were selected. These patients were divided into observation group and control group according to a random number table, 25 cases in each group. The patients in control group were given pseudo-rTMS stimulation therapy, while the observation group were given true rTMS stimula-tion therapy, then the auditory hallucinations score, serum BDNF levels of the two groups of patients were analyzed. Results After treatment, the auditory hallucinations score of the observation group was significantly lower (P<0.05); the serum BDNF levels after 2,4 weeks treatment of the observation group were significantly higher than those of the control group (P<0.05). Conclusion True rTMS stimulation therapy is more effective to enhance patient's BDNF lev-els, thereby greatly improve the auditory hallucinations than pseudo-rTMS stimulation therapy in the treatment of re-fractory auditory hallucinations patients.%目的:探讨难治性幻听患者应用rTMS治疗后幻听评分及血清BDNF水平的变化及意义。方法选择2011~2013年我院共收治50例难治性幻听患者,依据随机数字表法将患者分为观察组和对照组两组,每组25例。对照组患者采用假性rTMS刺激治疗,观察组患者采用真性rTMS刺激治疗,对两组患者的幻听评分、血清BDNF水平进行统计学分析。结果治疗后观察组患者的幻听评分明显比对照组低(P<0.05);治疗后2、4周观察组患者的血清BDNF水平均明显比对照组高(P<0.05)。结论难治性幻听患者应用真性rTMS刺激治疗较假性rTMS刺激治疗更能有效提升患者的BDNF水平,从而极大改善患者的幻听。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号